Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Disc Medicine, Inc. (IRON) Financial Statements

Free cash flow over the same period: -$197.6M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IRONDisc Medicine, Inc.Follow IRON — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 11 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 22 Oct; these figures move once the 10-Q is filed.

LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Research & development25.233.469.396.7170.6189.4
Operating income-30.9-47.5-91.1-129.7-236.0-269.3
Pre-tax income——-76.3-109.0-211.8-245.6
Income tax——0.10.40.40.3
Net income-36.0-46.8-76.4-109.4-212.2-245.9
Diluted EPS ($)-1.78-45.05-3.42-3.96-6.01-6.58
Diluted shares (mn)—1.022.327.635.3—

USD millions · SEC XBRL

Disc Medicine, Inc. — questions

What is Disc Medicine, Inc.'s net income?
-$245.9M over the twelve months to 2026-06-30.
What is Disc Medicine, Inc.'s free cash flow?
-$197.6M over the twelve months to 2026-06-30.
What are Disc Medicine, Inc.'s diluted earnings per share?
$-6.58 over the twelve months to 2026-06-30.

Every figure on this page comes from Disc Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.